{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:50:47Z","timestamp":1767909047497,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.pnpbp.2008.06.008","type":"journal-article","created":{"date-parts":[[2008,6,20]],"date-time":"2008-06-20T08:06:09Z","timestamp":1213949169000},"page":"1643-1651","source":"Crossref","is-referenced-by-count":40,"title":["Comparative remission rates of schizophrenic patients using various remission criteria"],"prefix":"10.1016","volume":"32","author":[{"given":"Romain","family":"Beitinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Kissling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2008.06.008_bib1","series-title":"Diagnostic and Statistical Manual for Mental Disorders, Third Revision, Revised (DSM-III-R)","author":"American Psychiatric Association","year":"1987"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib2","series-title":"Diagnostic and Statistical Manual For Mental Disorders, Fourth Edition","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"62","author":"Andreasen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0924-977X(96)00392-6","article-title":"Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial","volume":"7","author":"Beasley","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02245617","article-title":"Olanzapine versus placebo: results of a double-blind fixed dose olanzapine trial","volume":"124","author":"Beasley","year":"1996","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.pnpbp.2008.06.008_bib6","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1176\/appi.ajp.162.10.1879","article-title":"Olanzapine versus ziprasidone: results of the 28-week double-blind study in patients with schizophrenia","volume":"162","author":"Breier","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.schres.2006.12.032","article-title":"The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone","volume":"94","author":"Buckley","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.schres.2007.01.010","article-title":"Remission criteria for schizophrenia: evaluation in a large naturalistic cohort","volume":"92","author":"De Hert","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.schres.2006.09.013","article-title":"Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates","volume":"89","author":"Emsley","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib10","series-title":"Clinical global impressions. ECDEU Assessment Manual for Psychopharmacology, Revised (DHEW Publ No ADM 76-338)","first-page":"218","author":"Guy","year":"1976"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jpsychires.2006.07.005","article-title":"Remission and cognitive ability in a cohort of patients with schizophrenia","volume":"40","author":"Helldin","year":"2006","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.schres.2007.01.014","article-title":"Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders","volume":"93","author":"Helldin","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib13","first-page":"1","article-title":"Prediction of symptom remission in schizophrenia during inpatient treatment","author":"Jager","year":"2007","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.schres.2007.05.009","article-title":"Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52\u00a0weeks","volume":"95","author":"Kane","year":"2007","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.06.008_bib32","first-page":"62","article-title":"Clozaril Collaborative study group. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"24","author":"Kane","year":"1988","journal-title":"Psychopharmacol Bull"},{"issue":"Suppl 12","key":"10.1016\/j.pnpbp.2008.06.008_bib15","first-page":"5","article-title":"The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary","volume":"64","author":"Kane","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"issue":"11","key":"10.1016\/j.pnpbp.2008.06.008_bib17","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4088\/JCP.v67n1120","article-title":"Measurement based psychiatry in schizophrenia: definitions of response, remission, stability and relapse","volume":"67","author":"Leucht","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.06.008_bib18","first-page":"62","article-title":"Clinical implications of BPRS scores","volume":"187","author":"Leucht","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib19","unstructured":"Leucht S, Arbter D, Engel RR, Kissling W, Davis JM, in press-a. How effective are second generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Molecular Psychiatry. [advance online publication, 2008 Jan 8]."},{"issue":"4","key":"10.1016\/j.pnpbp.2008.06.008_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-007-0857-1","article-title":"On the concept of remission in schizophrenia","volume":"194","author":"Leucht","year":"2007","journal-title":"Psychopharmacology (Berl)."},{"issue":"9","key":"10.1016\/j.pnpbp.2008.06.008_bib21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.npp.1301325","article-title":"Defining 'response' in antipsychotic drug trials: recommendations for the use of scale derived cutoffs","volume":"32","author":"Leucht","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib22","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1176\/appi.ajp.160.8.1396","article-title":"Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol","volume":"160","author":"Lieberman","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2008.06.008_bib23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib24","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.clinthera.2006.11.007","article-title":"Measurable outcomes in psychiatric disorders: remission as a marker of wellness","volume":"28","author":"LMcIntyre","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00213-007-0730-2","article-title":"Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study","volume":"191","author":"Novick","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-244X-7-35","article-title":"Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings","volume":"7","author":"Opler","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2007.05.035","article-title":"Analysis of resolution criteria in patients with schizophrenia treated with olanzapine for an acute psychotic episode","volume":"95","author":"Peuskens","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/ajp.154.4.457","article-title":"Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial","volume":"154","author":"Tollefson","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004714-199710000-00010","article-title":"Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders","volume":"17","author":"Tran","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.06.008_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0447.2005.00659.x","article-title":"Standardized remission criteria in schizophrenia","volume":"113","author":"van Os","year":"2006","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.06.008_bib31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130100711","article-title":"Drop-out rates in randomised antipsychotic drug trials","volume":"155","author":"Wahlbeck","year":"2001","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608001887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608001887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T19:24:50Z","timestamp":1545938690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584608001887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0278584608001887"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2008.06.008","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}